Ruochan Chen

6.6k total citations · 5 hit papers
53 papers, 4.7k citations indexed

About

Ruochan Chen is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Ruochan Chen has authored 53 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Epidemiology and 14 papers in Cancer Research. Recurrent topics in Ruochan Chen's work include Advanced Glycation End Products research (10 papers), Hepatitis B Virus Studies (9 papers) and Hepatitis C virus research (9 papers). Ruochan Chen is often cited by papers focused on Advanced Glycation End Products research (10 papers), Hepatitis B Virus Studies (9 papers) and Hepatitis C virus research (9 papers). Ruochan Chen collaborates with scholars based in China, United States and Spain. Ruochan Chen's co-authors include Daolin Tang, Rui Kang, Xiaofang Sun, Xiaohua Niu, Zhanhui Ou, De Chen, Herbert J. Zeh, Xuegong Fan, Michael T. Lotze and Timothy R. Billiar and has published in prestigious journals such as The Journal of Immunology, Hepatology and Oncogene.

In The Last Decade

Ruochan Chen

52 papers receiving 4.7k citations

Hit Papers

Activation of the p62‐Keap1‐NRF2 pathway protects against... 2014 2026 2018 2022 2015 2014 2016 2022 2025 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells
    2015 1.6k citations Xiaofang Sun, Zhanhui Ou et al. Hepatology profile →
  2. HMGB1 in health and disease
    2014 787 citations Rui Kang, Ruochan Chen et al. profile →
  3. Metallothionein‐1G facilitates sorafenib resistance through inhibition of ferroptosis
    2016 549 citations Xiaofang Sun, Xiaohua Niu et al. Hepatology profile →
  4. The mechanism of HMGB1 secretion and release
    2022 530 citations Ruochan Chen, Rui Kang et al. profile →
  5. Pattern recognition receptors: function, regulation and therapeutic potential
    2025 30 citations Ruochan Chen, Ju Zou et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruochan Chen China 22 2.6k 1.9k 1.6k 822 725 53 4.7k
Lizhi Cao China 29 2.3k 0.9× 735 0.4× 857 0.5× 1.1k 1.3× 399 0.6× 47 3.8k
Minghua Yang China 29 2.3k 0.9× 1.1k 0.6× 1.2k 0.7× 749 0.9× 275 0.4× 95 4.0k
Sheng Tai China 29 1.7k 0.6× 528 0.3× 1.0k 0.6× 786 1.0× 135 0.2× 110 3.6k
Patricia Loughran United States 41 2.8k 1.1× 534 0.3× 613 0.4× 2.9k 3.5× 861 1.2× 109 7.0k
Chin‐Wen Chi Taiwan 38 2.0k 0.8× 376 0.2× 841 0.5× 381 0.5× 136 0.2× 77 3.7k
Manxiang Li China 30 2.2k 0.8× 1.0k 0.5× 500 0.3× 421 0.5× 93 0.1× 140 4.2k
Wei Chao United States 38 1.8k 0.7× 382 0.2× 555 0.4× 1.3k 1.6× 105 0.1× 110 4.4k
Tian Lan China 38 2.3k 0.9× 338 0.2× 892 0.6× 630 0.8× 87 0.1× 134 4.5k
Yan Yu China 30 1.5k 0.6× 348 0.2× 863 0.5× 382 0.5× 263 0.4× 73 2.8k
Su Wol Chung South Korea 32 2.5k 1.0× 1.1k 0.6× 1.0k 0.6× 753 0.9× 56 0.1× 77 4.3k

Countries citing papers authored by Ruochan Chen

Since Specialization
Citations

This map shows the geographic impact of Ruochan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruochan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruochan Chen more than expected).

Fields of papers citing papers by Ruochan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruochan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruochan Chen. The network helps show where Ruochan Chen may publish in the future.

Co-authorship network of co-authors of Ruochan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Ruochan Chen. A scholar is included among the top collaborators of Ruochan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruochan Chen. Ruochan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Zhou, Hui, Hai Li, Guohong Deng, et al.. (2025). A novel model for identifying infections in patients with AoCLD: a nationwide, multicenter, prospective cohort study. QJM. 118(7). 489–500. 1 indexed citations
4.
Chen, Ruochan, et al.. (2024). Immune aging and infectious diseases. Chinese Medical Journal. 137(24). 3010–3049. 5 indexed citations
5.
Li, Hai, Guohong Deng, Xianbo Wang, et al.. (2024). sTREM-1 as promising prognostic biomarker for acute-on-chronic liver failure and mortality in patients with acute decompensation of cirrhosis. World Journal of Gastroenterology. 30(9). 1177–1188. 1 indexed citations
6.
Chen, Ruochan, et al.. (2023). HMGB1 in the interplay between autophagy and apoptosis in cancer. Cancer Letters. 581. 216494–216494. 36 indexed citations
7.
8.
Zhong, Xiao Yan, Xuegong Fan, & Ruochan Chen. (2023). Repurposing Niclosamide as a Therapeutic Drug against Acute Liver Failure by Suppressing Ferroptosis. Pharmaceutics. 15(7). 1950–1950. 5 indexed citations
9.
10.
Chen, Ruochan, et al.. (2022). Safety and Efficacy of Tenofovir Alafenamide Fumarate in Early-Middle Pregnancy for Mothers With Chronic Hepatitis B. Frontiers in Medicine. 8. 796901–796901. 13 indexed citations
11.
Chen, Jun, Min Qi, Xuegong Fan, et al.. (2021). Efficacy of Peginterferon alfa-2b in Nucleoside Analogue Experienced Patients with Negative HBeAg and Low HBsAg: A Non-Randomized Clinical Trial. Infectious Diseases and Therapy. 10(4). 2259–2270. 12 indexed citations
12.
Chen, Ruochan, Yayu Chen, Ying Xue, et al.. (2021). Suboptimal Response to Tenofovir Alafenamide in Two Patients With HBeAg-Positive Hepatitis B: A Case Report. Frontiers in Medicine. 8. 701061–701061. 3 indexed citations
13.
Chen, Ruochan, Yiya Zhang, Pengcheng Zhou, et al.. (2020). Cryptococcemia According to Immune Status: An Analysis of 65 Critical Cases. Infectious Diseases and Therapy. 10(1). 363–371. 4 indexed citations
14.
Chen, Ruochan & Yiya Zhang. (2020). EPDR1 correlates with immune cell infiltration in hepatocellular carcinoma and can be used as a prognostic biomarker. Journal of Cellular and Molecular Medicine. 24(20). 12107–12118. 13 indexed citations
15.
Chen, Ruochan, Ling Zeng, Shan Zhu, et al.. (2019). cAMP metabolism controls caspase-11 inflammasome activation and pyroptosis in sepsis. Science Advances. 5(5). eaav5562–eaav5562. 116 indexed citations
16.
Li, Ning, Zebing Huang, Ruochan Chen, et al.. (2018). A novel lncRNA, TCONS_00006195, represses hepatocellular carcinoma progression by inhibiting enzymatic activity of ENO1. Cell Death and Disease. 9(12). 1184–1184. 48 indexed citations
17.
Chen, Ruochan, Juan Wang, Fang Peng, et al.. (2017). Integrated analysis of microRNA and mRNA expression profiles in HBx-expressing hepatic cells. World Journal of Gastroenterology. 23(10). 1787–1787. 12 indexed citations
18.
Sun, Xiaofang, Zhanhui Ou, Ruochan Chen, et al.. (2015). Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 63(1). 173–184. 1566 indexed citations breakdown →
19.
Chen, Ruochan, Sha Fu, Xuegong Fan, et al.. (2015). Nuclear DAMP complex-mediated RAGE-dependent macrophage cell death. Biochemical and Biophysical Research Communications. 458(3). 650–655. 27 indexed citations
20.
Huang, Zebing, Xiahong Dai, Meifang Xiao, et al.. (2013). HMGB1 release by human liver L02 and HepG2 cells induced by lipopolysaccharide. Molecular Medicine Reports. 8(1). 103–112. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lizhi Cao Breakdown of academic impact, for papers by Minghua Yang Breakdown of academic impact, for papers by Sheng Tai Breakdown of academic impact, for papers by Patricia Loughran Breakdown of academic impact, for papers by Chin‐Wen Chi Breakdown of academic impact, for papers by Manxiang Li Breakdown of academic impact, for papers by Wei Chao Breakdown of academic impact, for papers by Tian Lan Breakdown of academic impact, for papers by Yan Yu Breakdown of academic impact, for papers by Su Wol Chung
Rankless by CCL
2026